Clovibactin: A revolutionary antibiotic unleashing lethal efficacy against pathogens with little drug resistance
- 26 December 2023
- journal article
- editorial
- Published by Elsevier in Science Bulletin
- Vol. 69 (5) , 570-573
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (12090052)
- Ministry of Science and Technology of the People's Republic of China (2021ZD0201900)
- Natural Science Foundation of Fujian Province (2023J05002)
- Fundamental Research Funds for the Central Universities (20720230017)
This publication has 9 references indexed in Scilit:
- An antibiotic from an uncultured bacterium binds to an immutable targetCell, 2023
- Teixobactin kills bacteria by a two-pronged attack on the cell envelopeNature, 2022
- Mosaic composition of RIP1–RIP3 signalling hub and its role in regulating cell deathNature Cell Biology, 2022
- Antibiotic resistance in the environmentNature Reviews Microbiology, 2021
- Towards the sustainable discovery and development of new antibioticsNature Reviews Chemistry, 2021
- The Science of Antibiotic DiscoveryCell, 2020
- An environmental bacterial taxon with a large and distinct metabolic repertoireNature, 2014
- Higher-Order Assemblies in a New Paradigm of Signal TransductionCell, 2013
- The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteriaThe Lancet Infectious Diseases, 2013